E/CN.7/2015/1

Provisional agenda and annotations

E/CN.7/2015/2* - E/CN.15/2015/2*

Report of the Executive Director on the activities of the United Nations Office on Drugs and Crime

E/CN.7/2015/3*

Report of the Secretariat on the world situation with regard to drug abuse

E/CN.7/2015/4

Report of the Secretariat on the world situation with regard to drug trafficking

E/CN.7/2015/5

Report of the Secretariat on action by the subsidiary bodies of the Commission on Narcotic Drugs

E/CN.7/2015/6 - E/CN.15/2015/6

Note by the Secretariat on the work of the standing open-ended working group on improving the governance and financial situation of the United Nations Office on Drugs and Crime

E/CN.7/2015/7

Note by the Secretariat on changes in the scope of control of substances [Mephedrone and Ketamine]

E/CN.7/2015/7/Add.1

Addendum: Note by the Secretariat on changes in the scope of control of substances [Mephedrone and Ketamine]

E/CN.7/2015/8

Note by the Secretariat on the scope of control of substances: proposed scheduling recommendations initiated by WHO

E/CN.7/2015/9

Note by the Secretariat on promoting coordination and alignment of decisions between the Commission on Narcotic Drugs and the Programme Coordinating Board of the Joint United Nations Programme on HIV/AIDS

E/CN.7/2015/10

Report by the Secretariat on the implementation of resolutions and decisions relating to the drug programme of the United Nations Office on Drugs and Crime adopted since 2012 in which action by the Office was requested

E/CN.7/2015/11

Report of ED on Enhancing international cooperation to strengthen efforts in West Africa to counter illicit drug trafficking

E/CN.7/2015/12

Report of ED on Strengthening international cooperation in combating illicit opiates originating in Afghanistan through continuous and reinforced support to the Paris Pact initiative

E/CN.7/2015/14

Legal Opinion from the Office of Legal Affairs 

E/2015/28-E/CN.7/2015/15

Commission on Narcotic Drugs, Report on the fifty-eighth session

E/CN.7/2015/CRP.1

Reports by intergovernmental organizations on drug control activities

E/CN.7/2015/CRP.2

UNODC-WHO Expert Consultation on New Psychoactive Substances, Vienna, 9-11 December 2014

E/CN.7/2015/CRP.3

Updated background paper prepared by the United Kingdom of Great Britain and Northern Ireland related to its notification submitted on 23 January to the Secretary-General on the review of the scope of control of mephedrone

E/CN.7/2015/CRP.5

Further information provided by the People's Republic of China on the proposed scheduling of ketamine

E/CN.7/2015/CRP.6

Statements of financial implications presented to the Commission on Narcotic Drugs before its consideration of draft resolutions at its fifty-eighth session

E/CN.7/2015/CRP.7

List of documents before the Commission at its fifty-eighth session

E/CN.7/2014/10

Note by the Secretariat on the challenges and future work in the review of substances for possible scheduling recommendations

WHO Technical Report Series 991

36th report of the WHO Expert Committee on Drug Dependence (Pre-layout version)

E/CN.7/2015/13

Note by the Secretariat on Special session of the General Assembly on the world drug problem to be held in 2016

E/CN.7/2015/CRP.4

Background documentation for the interactive discussions on high-level segments to the held during the special session of the General Assembly on the world drug problem in 2016

E/CN.7/2014/17

Note by the Secretariat on the preparations for the possible outcomes of, and organizational matters relating to the special session of the General Assembly on the World Drug Problem in 2016

E/CN.7/2014/CRP.15

A C E F R S

Special segment: proposals by the Chair of the fifty-seventh session of the Commission on Narcotic Drugs relating to the special session of the General Assembly on the world drug problem to be held in 2016 for consideration by the Commission

E/CN.7/2015/NGO.1

Written statement submitted by EURAD

E/CN.7/2015/NGO.2

Written statement submitted by the Vienna NGO Committee on Drugs